Supernus Pharmaceuticals Inc (SUPN)
30.84
+0.57
(+1.88%)
USD |
NASDAQ |
May 03, 16:00
30.84
0.00 (0.00%)
After-Hours: 20:00
Supernus Pharmaceuticals Total Long Term Debt (Quarterly): 0.00 for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 480.86M |
December 31, 2022 | 401.97M |
September 30, 2022 | 401.44M |
June 30, 2022 | 400.91M |
March 31, 2022 | 400.38M |
December 31, 2021 | 379.25M |
September 30, 2021 | 374.79M |
June 30, 2021 | 370.38M |
March 31, 2021 | 366.04M |
December 31, 2020 | 361.75M |
September 30, 2020 | 357.52M |
June 30, 2020 | 353.35M |
March 31, 2020 | 349.23M |
December 31, 2019 | 345.17M |
September 30, 2019 | 341.16M |
June 30, 2019 | 337.21M |
March 31, 2019 | 333.31M |
December 31, 2018 | 329.46M |
September 30, 2018 | 325.67M |
June 30, 2018 | 321.92M |
March 31, 2018 | 318.22M |
December 31, 2017 | 0.00 |
Date | Value |
---|---|
September 30, 2017 | 0.00 |
June 30, 2017 | 1.472M |
March 31, 2017 | 3.31M |
December 31, 2016 | 4.165M |
September 30, 2016 | 5.772M |
June 30, 2016 | 5.699M |
March 31, 2016 | 5.627M |
December 31, 2015 | 7.085M |
September 30, 2015 | 8.068M |
June 30, 2015 | 8.762M |
March 31, 2015 | 11.71M |
December 31, 2014 | 26.22M |
September 30, 2014 | 26.50M |
June 30, 2014 | 28.67M |
March 31, 2014 | 28.36M |
December 31, 2013 | 34.39M |
September 30, 2013 | 60.18M |
June 30, 2013 | 59.10M |
March 31, 2013 | 20.11M |
December 31, 2012 | 22.90M |
September 30, 2012 | 25.61M |
June 30, 2012 | 27.81M |
March 31, 2012 | 29.10M |
December 31, 2011 | 29.49M |
September 30, 2011 | 89.51M |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2023
480.86M
Maximum
Mar 2023
316.92M
Average
361.75M
Median
Dec 2020
Total Long Term Debt (Quarterly) Benchmarks
Dynavax Technologies Corp | 222.70M |
Ligand Pharmaceuticals Inc | 0.00 |
Pacira BioSciences Inc | 522.44M |
Esperion Therapeutics Inc | 261.60M |
Collegium Pharmaceutical Inc | 667.17M |